Provided by Tiger Fintech (Singapore) Pte. Ltd.

AC Immune SA

1.73
+0.03001.76%
Volume:130.93K
Turnover:217.47K
Market Cap:171.17M
PE:-3.07
High:1.75
Open:1.70
Low:1.55
Close:1.70
Loading ...

AC Immune SA Reports 2024 Financial Results and Strategic Advances

TIPRANKS
·
13 Mar

AC Immune FY24 EPS CHF(0.51) vs CHF(0.64) YoY; Contract Revenues CHF27.3M

Benzinga
·
13 Mar

AC Immune Sa: Cash Resources of CHF 165.5 Million at Year End Provides Funding Into Q1 2027

THOMSON REUTERS
·
13 Mar

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Dow Jones
·
13 Mar

AC Immune SA expected to post a loss of 19 rappen a share - Earnings Preview

Reuters
·
10 Mar

AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know

Zacks
·
06 Mar

New Strong Buy Stocks for March 5th

Zacks
·
05 Mar

AC Immune to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Mar

Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)

Zacks
·
13 Feb

ACRES received 15 tip-offs for illegal snake-keeping last year

CNA
·
07 Feb

New Strong Buy Stocks for January 31st

Zacks
·
31 Jan

AC Immune Sa : Jefferies Cuts Target Price to $7 From $8

THOMSON REUTERS
·
08 Jan

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

Simply Wall St.
·
03 Jan

AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2

TipRanks
·
11 Dec 2024

AC Immune Reports Interim Safety Data From Phase 1B/2 Abate Trial of ACI-24.060 in Down Syndrome

THOMSON REUTERS
·
10 Dec 2024

AC Immune Sa - ACI-24.060 Safe and Well Tolerated in Down Syndrome Patients

THOMSON REUTERS
·
10 Dec 2024

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

GlobeNewswire
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)

TIPRANKS
·
19 Nov 2024

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

TipRanks
·
15 Nov 2024

AC Immune Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024